Concepedia

Masaichi Warizaya

MW

Statistics

Publications

16

Citations

662

H-Index

13

Active since

2003

Affiliations

Astellas Pharma (Japan)(Current)

Fujisawa City Hospital

Mochida Pharmaceutical (Japan)

The University of Osaka

Osaka Prefecture University

Masaichi Warizaya is an author at Astellas Pharma (Japan) specializing in life sciences, structural biology, and enzymology.

Publications per year

2003–2013

16

Publications

16

Inhibitor‐induced structural change of the active site of human poly(ADP‐ribose) polymerase

Takayoshi Kinoshita, Isao Nakanishi, Masaichi Warizaya et al. · FEBS Letters · 2003 · 92 citations · Full text

, , +17

Role of a cysteine residue in the active site of ERK and the MAPKK family

Makoto Ohori, Takayoshi Kinoshita, Seiji Yoshimura et al. · Biochemical and Biophysical Research Communications · 2006 · 84 citations

, , +14

Discovery of potent and selective PARP-1 and PARP-2 inhibitors: SBDD analysis via a combination of X-ray structural study and homology modeling

Junya Ishida, Hirofumi Yamamoto, Yoshiyuki Kido et al. · Bioorganic & Medicinal Chemistry · 2005 · 82 citations · Full text

, , +15

Discovery of quinazolinone and quinoxaline derivatives as potent and selective poly(ADP‐ribose) polymerase‐1/2 inhibitors

Akinori Iwashita, Kouji Hattori, Hirofumi Yamamoto et al. · FEBS Letters · 2005 · 76 citations

, , +17

4-Hydroxypyridazin-3(2<i>H</i>)-one Derivatives as Novel<scp>d</scp>-Amino Acid Oxidase Inhibitors

Takeshi Hondo, Masaichi Warizaya, Tatsuya Niimi et al. · Journal of Medicinal Chemistry · 2013 · 45 citations · Full text

, , +17

1–5 of 16